REBECCA ARONOFF: Open Payments
NPI 1427188275 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 74 payments from 14 companies in 2025. Trend: 2023 $1,652 · 2024 $1,703 · 2025 $1,762
Food & beverage: $1,662Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $326 |
| Arcutis Biotherapeutics, Inc. | 5 | $242 |
| Novartis Pharmaceuticals Corporation | 8 | $206 |
| Janssen Biotech, Inc. | 7 | $182 |
| PFIZER INC. | 8 | $180 |
| UCB, Inc. | 12 | $168 |
| GENZYME CORPORATION | 6 | $161 |
| Amgen Inc. | 1 | $125 |
| Organon LLC | 6 | $63 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
Products named: SKYRIZI, Zoryve, DUPIXENT, TREMFYA, Bimzelx, OTEZLA, LITFULO, Rhapsido.
Industry payments across CO — which companies pay providers there.
